Your Health, We Care
Based on the results of clinical trials, the FDA officially approved Aprocitentan (trade name Tryvio) for marketing on March 19, 2024, for the treatment of refractory hypertension patients.
This is the first drug with innovative mechanisms in the field of hypertension in over 30 years, providing a new option for the treatment of cardiovascular diseases.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
